LADENBURG THALMANN FINANCIAL SERVICES INC. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 82 filers reported holding ANTARES PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q4 2019$10,000
-67.7%
1,504
-83.8%
0.00%
Q3 2019$31,000
+34.8%
9,260
+33.2%
0.00%
Q2 2019$23,000
+21.1%
6,950
+11.0%
0.00%
Q1 2019$19,0000.0%6,260
-9.5%
0.00%
Q4 2018$19,000
-17.4%
6,914
+0.8%
0.00%
Q3 2018$23,000
+21.1%
6,860
-22.6%
0.00%
Q2 2018$19,0000.0%8,8600.0%0.00%
Q1 2018$19,000
+18.8%
8,860
+7.3%
0.00%
Q4 2017$16,000
-42.9%
8,260
-5.7%
0.00%
Q3 2017$28,0000.0%8,7600.0%0.00%
Q2 2017$28,000
+12.0%
8,7600.0%0.00%
Q1 2017$25,000
+25.0%
8,7600.0%0.00%
Q4 2016$20,000
+42.9%
8,760
+6.1%
0.00%
Q3 2016$14,000
+55.6%
8,2600.0%0.00%
Q2 2016$9,000
+28.6%
8,260
+6.4%
0.00%
Q1 2016$7,000
+250.0%
7,760
+1452.0%
0.00%
Q4 2013$2,0000.0%5000.0%0.00%
Q3 2013$2,0000.0%5000.0%0.00%
Q2 2013$2,0005000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders